|
Securing access to innovative anticancer therapies for children, adolescents, and young adults outside clinical trials: The SACHA study of the French Society of Pediatric Oncology (SFCE). |
|
|
Consulting or Advisory Role - Bayer (Inst); EUSA Pharma (Inst) |
Research Funding - Bayer (Inst) |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca/Merck |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - BMS (Inst); BMS (Inst) |
Travel, Accommodations, Expenses - BMS |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Dominique Valteau-Couanet |
No Relationships to Disclose |
|
|
Honoraria - EUSA Pharma (Inst) |
Travel, Accommodations, Expenses - EUSA Pharma; Jazz Pharmaceuticals |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Lilly; Novartis; Roche/Genentech |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche |